After entering tumor cells, the siRNAs could inhibit HIF-1α expression and block the downstream fatty acid transporters fatty acid binding protein (FABP) 3 and FABP7 to deplete the lipid droplet pool in tumor cells. Here, FABP7 is linked to neoplasm.